MB02
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for MB02, covering 2020-06-16 to 2021-03-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) [Phase 3]